Two authoritative obesity experts debate whether the benefit of anti-obesity drugs outweigh their potential medical risks. Bray argues that even modest drug induced weight loss reduces obesity complications (hypertension, coronary disease, diabetes), while Hirsch argues for a moratorium until drugs can be better targeted to specific causes of obesity yet to be defined. To see a full text version of this article, please
click here to view the PDF.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.